Literature DB >> 23291111

Replica exchange molecular dynamics simulation of chitosan for drug delivery system based on carbon nanotube.

Chompoonut Rungnim1, Thanyada Rungrotmongkol, Supot Hannongbua, Hisashi Okumura.   

Abstract

Chitosan is an important biopolymer in the medical applications because of its excellent biocompatibility. It has been recently highlighted in the targeted drug delivery system (DDS) by improvement of the carbon nanotube (CNT) solubility. To investigate the effect of chitosan length, the two targeted DDSs with 30 and 60 chitosan monomers were performed by replica-exchange molecular dynamics simulations at temperatures in the range of 300-455K with three different combinations of force fields and implicit solvation models. Each DDS model contains the epidermal growth factor (EGF), chitosan (CS) of 30 (30CS) and 60 (60CS) monomers, single-wall CNT (SWCNT) and gemcitabine (Gemzar) as the model payload anticancer drug, called EGF/30CS/SWCNT/Gemzar and EGF/60CS/SWCNT/Gemzar, respectively. The SWCNT confines gemcitabine inside its cavity, while the outer surface is wrapped by chitosan in which one end is linked to the EGF. Even though the REMD results from different force fields and implicit solvation models are not exactly identical, all of them are in the same trend confirming that in the EGF/30CS/SWCNT/Gemzar DDS the 30CS chain was not long enough to wrap around the SWCNT, and consequently the EGF was located so close to the tube as to potentially cause steric inhibition of the binding of EGF to its receptor (EGFR), which is highly expressed on the surface of cancer cells. On the other hand, this phenomenon is not observed in the EGF/60CS/SWCNT/Gemzar DDS in which the 60CS was found to completely wrap over the CNT outer surface using only 50 chitosan units. The evidence suggested that a ratio of chitosan molecular weight per SWCNT surface area larger than 9.9×10(-7)kg/m(2) is suitable for application in targeted DDSs. Although an increase in the temperature is likely to influence the overall DDS structure, and especially the orbit of helical chitosan on the SWCNT and the EGF conformation, gemcitabine is still encapsulated inside the tube.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23291111     DOI: 10.1016/j.jmgm.2012.11.004

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  4 in total

1.  Molecular dynamics simulation study of chitosan and gemcitabine as a drug delivery system.

Authors:  Fariba Razmimanesh; Sepideh Amjad-Iranagh; Hamid Modarress
Journal:  J Mol Model       Date:  2015-06-06       Impact factor: 1.810

2.  Poly (n-butyl cyanoacrylate) as a nanocarrier for rivastigmine transport across the blood-brain barrier in Alzheimer's disease treatment: a perspective from molecular dynamics simulations.

Authors:  Seyed Vahid Mousavi; Seyed Majid Hashemianzadeh
Journal:  J Mol Model       Date:  2018-08-25       Impact factor: 1.810

3.  Molecular interaction mechanisms of glycol chitosan self-healing hydrogel as a drug delivery system for gemcitabine and doxorubicin.

Authors:  Tzu-Hsuan Huang; Shan-Hui Hsu; Shu-Wei Chang
Journal:  Comput Struct Biotechnol J       Date:  2022-01-25       Impact factor: 7.271

4.  Designing a high-performance smart drug delivery system for the synergetic co-absorption of DOX and EGCG on ZIF-8.

Authors:  Ahmad Haghi; Heidar Raissi; Hassan Hashemzadeh; Farzaneh Farzad
Journal:  RSC Adv       Date:  2020-12-17       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.